{
  "id": 9405722,
  "title": "Zymeworks Completes Acquisition of Theravance Biopharma",
  "url": "https://urgent.news/2026/09/23/zymeworks-completes-acquisition-of-theravance-biopharma",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-23T20:05:27.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/zymeworks-completes-acquisition-of-theravance-biopharma"
  },
  "original_language": "en",
  "account": null,
  "summary": "Conference call with Zymeworks management on September 28 at 8:30 am Eastern Time (ET) VANCOUVER, British Columbia, Sept. 23, 2026 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel, multifunctional biotherapeutics, today completed the previously announced acquisition of…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}